Thus, CHRF functions as an endogenous sponge to inhibit miR-489 activity and affect MyD88 levels, contributing to myocardial hypertrophy (Wang et al., 2014; Zhou et al., 2019). Here, MYD88 is linked to cardiac hypertrophy.